Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia
Study sponsor: Spruce Biosciences
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2019-03-02Actual
Enrollment · participants24Actual
Source updated2025-10-22Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.